603739.SH
蔚蓝生物
SSE · Healthcare · Biotechnology · CN
CNY 12.05
−1.95%Margins
Gross margin
44.8%
EBITDA margin
17.5%
EBIT margin
9.7%
Net margin
5.6%
FCF margin
5.1%
4.3%
Return on equity
2.5%
Return on assets
5.5%
Return on invested capital
0.46x
Asset turnover
CNY 124.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026